Zealand Pharma A/S holds the cleaner structural position, with the lead spread across profitability and valuation. QXO does not offset that deficit through any equally strong structural edge elsewhere. Both sides have seen trend damage — neither carries a clear market edge right now. With both trends damaged, the structural comparison carries most of the weight here.
The comparison is based on similar long-term financial trajectories, not sector labels.
Most of the separation is still concentrated in profitability. Zealand Pharma A/S leads by 38 points on the overall comparison score.
This pair is matched through long-term financial trajectory similarity within the selected peer universe.
The pair shares a valid long-term profile match, but the trajectories are not especially close.
The clearest structural overlap shows up in revenue growth trajectory and investment intensity.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
Score differences across key dimensions.
Left means cheaper relative valuation. Higher means stronger structure.
Zealand Pharma A/S looks stronger both structurally and on relative valuation.
Valuation position uses Forward P/E and peer-relative PE percentile (idx_pct_pe) where available.
Capital efficiency adds support, with a 4996-point ROIC advantage.
QXO, Inc. still looks less cycle-sensitive — that keeps the result from looking completely one-sided.
The lead is built on both profitability and valuation, making it broader than a single-dimension result.
Break down the QXO vs ZEAL.CO comparison across all dimensions with the full interactive tool.
Explore how QXO and ZEAL.CO each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.